As of Apr 20
| +0.005 / +0.18%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 65.00, with a high estimate of 65.00 and a low estimate of 65.00. The median estimate represents a +2,255.07% increase from the last price of 2.76.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.